University of Minnesota. Driven to Discover.
Steeply dropping cases, though, may cause the NIAID to vary from the original trial design.
Faced with new data, the ACIP drops its preference for nasal-spray flu vaccine in 2- to 8-year-olds.
The WHO notes signs that flu strains, especially avian ones, are co-circulating at unprecedented levels.
Presidential panel finds "a failure to prepare and a failure to follow good science."
A Scottish study of this year's vaccine found effectiviness of 33%, higher than elsewhere.
The CDC says the findings point to a need for better antibiotic stewardship and infection control.
Get CIDRAP news.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2015 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.